Korro Bio (KRRO) Misses Q1 EPS by 249c

Korro Bio (NASDAQ: KRRO) reported Q1 EPS of ($2.49). Revenue for the quarter came in at $2.55 million.

For earnings history and earnings-related data on Korro Bio (KRRO) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• Freedom Broker Upgrades PrimeEnergy Resource (PNRG) to Hold
• Stifel on EyePoint Inc. (EYPT): 'we think these data bode well for LUCIA (expected October) barring another unusual asymmetry'